Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지
DOI QR코드

DOI QR Code

Trends and Appropriateness of Outpatient Prescription Drug Use in Veterans

보훈의료지원 대상자의 외래 처방의약품 사용경향과 적정성 평가

  • Received : 2018.03.18
  • Accepted : 2018.06.12
  • Published : 2018.06.29
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: This study analyzed the national claims data of veterans to generate scientific evidence of the trends and appropriateness of their drug utilization in an outpatient setting. Methods: The claims data were provided by the Health Insurance Review & Assessment (HIRA). Through sampling and matching data, we selected two comparable groups; Veterans vs. National Health Insurance (NHI) patients and Veterans vs. Medical Aid (MAID) patients. Drug use and costs were compared between groups by using multivariate gamma regression models to account for the skewed distribution, and therapeutic duplication was analyzed by using multivariate logistic regression models. Results: In equivalent conditions, veteran patients made fewer visits to medical institutions (0.88 vs. 1), had 1.86 times more drug use, and paid 1.4 times more drug costs than NHI patients (p<0.05); similarly, veteran patients made fewer visits to medical institutions (0.96 vs. 1), had 1.11 times more drug use, and paid 0.95 times less drug costs than MAID patients (p<0.05). The risk of therapeutic duplication was 1.7 times higher (OR=1.657) in veteran patients than in NHI patients and 1.3 times higher (OR=1.311) than in MAID patients (p<0.0001). Conclusion: Similar patterns of drug use were found in veteran patients and MAID patients. There were greater concerns about the drug use behavior in veteran patients, with longer prescribing days and a higher rate of therapeutic duplication, than in MAID patients. Efforts should be made to measure if any inefficiency exists in veterans' drug use behavior.

Keywords

References

  1. Ministry of Patriols and Veterans Affairs. Medical care benefits for veterans. Available from http://www.mpva.go.kr/support/support250_list.asp?page=1&ipp=10. Accessed March 2, 2018.
  2. Ministry of Patriols and Veterans Affairs. Annual report of patriots and veterans affairs 2014. Sejong: Ministry of Patriols and Veterans Affairs; 2015.
  3. Jeong Y. Differences of health outcome indicators including mortality according to polypharmacy in elderly male visiting a veterans hospital: Ulsan University; 2011.
  4. Shin Y, Shin H, Hwang D, et al. Improving the reimbursement scheme for veterans hospitals. Seoul: Korea Veterans Health Service, Korea Institute for Health and Social Affairs; 2007.
  5. Heo Y. A study on drug awareness information, usage and misusage on elderly inpatients of veterans hospital. J Korea Academia-Industrial Coop Soc 2013;14(9):4326-34. https://doi.org/10.5762/KAIS.2013.14.9.4326
  6. Health Insurance Review & Assessment Service. Healthcare bigdata hub. Available from http://opendata.hira.or.kr/op/opc/selectPatDataAplInfoView.do. Accessed March 13, 2018.
  7. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43(11):1130-9. https://doi.org/10.1097/01.mlr.0000182534.19832.83
  8. Lieffers JR, Baracos VE, Winget M, et al. A comparison of Charlson and Elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data. Cancer 2011;117(9):1957-65. https://doi.org/10.1002/cncr.25653
  9. Kim KH. Comorbidity adjustment in health insurance claim database. Health Policy and Management. 2016;26(1):71-8. https://doi.org/10.4332/KJHPA.2016.26.1.71
  10. U.S. Congress. H.R. 5835 (101st): Omnibus Budget Reconciliation Act of 1990. Available from https://www.govtrack.us/congress/bills/101/hr5835. Accessed March 12, 2018.
  11. Kim D, Kang H, Lee S, et al. Developing the drug utilization review standard on therapeutic duplication. Seoul: Health Insurane Review & Assessment Service; 2012.
  12. Ministry of Health & Welfare. Operational guideline of drug utilization review. Sejong: Ministry of Health & Welfare; 2015.
  13. Suh HS, Kang HY, Kim J, et al. Effect of health insurance type on health care utilization in patients with hypertension: a national health insurance database study in Korea. BMC Health Serv Res 2014;14:570. https://doi.org/10.1186/s12913-014-0570-9
  14. FirstDis. Survey on appropriate use of medications by Medical Aid beneficiary. Seoul: FirstDis.
  15. Barr N. Insurance. Economics of the welfare state. 4th ed. Oxford: Oxford University Press; 2004. 102-20.
  16. Barr N. Health and health care. Economics of the welfare state. 4th ed: Oxford University Press; 2004. 253-92.
  17. Hayek FA. The use of knowledge in society. Am Econ Rev 1945;35(4):519-30.
  18. Kim C. Types and configuration of health care system. Theories of health security. Seoul: Hanul Academy, 2009:105-31.
  19. Thomson S, Mossialos E. Influencing demand for durgs through cost sharing. In: Mossialos E, Mrazek M, Walley T, editors. Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Maidenhead: Open University Press, 2004:227-44.
  20. Lee I-H, Bloor K, Hewitt C, et al. International experience in controlling pharmaceutical expenditure: influencing patients and providers and regulating industry - a systematic review. J Health Serv Res Policy 2015;20(1):52-9. https://doi.org/10.1177/1355819614545675
  21. Soumerai SB, Ross-Degnan D, Avorn J, et al. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991;325(15):1072-7. https://doi.org/10.1056/NEJM199110103251505
  22. Soumerai SB. Benefits and risks of increasing restrictions on access to costly drugs in Medicaid Health Aff 2004;23(1):135-46. https://doi.org/10.1377/hlthaff.23.1.135
  23. Jacobzone S. Pharmaceutical policies in OECD countries: reconciling social and industrial goals. Paris: Organisation for Economic Co-operation and Development; 2000.
  24. Malehi AS, Pourmotahari F, Angali KA. Statistical models for the analysis of skewed healthcare cost data: a simulation study. Health Econ Rev 2015;5:11. https://doi.org/10.1186/s13561-015-0045-7
  25. Chazard E, Ficheur G, Beuscart JB, et al. How to Compare the Length of Stay of Two Samples of Inpatients? A Simulation Study to Compare Type I and Type II Errors of 12 Statistical Tests. Value Health 2017;20(7):992-8. https://doi.org/10.1016/j.jval.2017.02.009

Cited by

  1. 보훈환자 시각에서의 처방의약품 사용 행태와 영향요인 vol.30, pp.3, 2018, https://doi.org/10.24304/kjcp.2020.30.3.185